发明名称 Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease
摘要 <p>Drug products for use in treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.</p>
申请公布号 AU2006284841(A1) 申请公布日期 2007.03.08
申请号 AU20060284841 申请日期 2006.08.30
申请人 SCHERING CORPORATION;THE GOVERNMENT OF THE UNITED STATES OF AMERICA ASREPRESENTED BY THE SECRETARY OF THE DEPARTMENT OFHEALTH AND HUMAN SERVICES 发明人 RACHEL CASPI;ROBERT A. KASTELEIN;VAN T. TSAI;PHYLLIS SILVER;DROR LUGER;DANIEL J. CUA
分类号 A61K39/395;A61P27/00 主分类号 A61K39/395
代理机构 代理人
主权项
地址